Liang Bin, Peng Yufu, Yang Wugui, Yang Yubo, Li Bo, Wei Yonggang, Liu Fei
Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, No. 37 Guoxue Lane, Chengdu, Sichuan Province 610041, China.
Therap Adv Gastroenterol. 2025 Jun 23;18:17562848251348974. doi: 10.1177/17562848251348974. eCollection 2025.
The harmonic scalpel (HS) and cavitron ultrasonic surgical aspirator (CUSA) are two common techniques for liver parenchymal transection (LPT). The second International Consensus Conference on laparoscopic liver resection (LLR) recommended the utilization of the HS for superficial layer LPT and the CUSA for deep layer LPT. Some centers currently employ the HS for deep-layer LPT. However, the potential effect of HS during deep layer transection in LLR remains unclear.
The study aims to investigate the feasibility, safety, and efficiency of HS in LLR compared with CUSA.
This is a study protocol for a randomized controlled trial (RCT).
This RCT will be carried out at West China Hospital of Sichuan University from January 2024 to December 2025. Consecutive patients who underwent LLRs during this period will be recruited based on the specified inclusion and exclusion criteria. The participants will be randomly allocated to the HS group or the CUSA group. The primary outcome is intraoperative blood loss. Secondary outcomes include parenchymal transection velocity, operative time, conversion rate, postoperative hospital stays, hospital cost, morbidity, and mortality. Subgroup analysis will be performed according to liver cirrhosis. The corresponding statistical approach will be used for statistical analysis.
The trial has been reviewed and approved by the Biomedical Ethics Review Committee of West China Hospital, Sichuan University, on January 19, 2024.
This study will clarify the feasibility, safety, and efficiency of HS for LPT in LLRs. The results will provide more reliable clinical evidence for the selection of LPT devices in LLRs.
The study protocol was registered in the Chinese Clinical Trial Registry (http://www.chictr.org.cn) on April 26, 2024, ChiCTR2400083493. The protocol version is V2.0.
超声刀(HS)和超声外科吸引器(CUSA)是肝实质离断(LPT)的两种常用技术。第二届腹腔镜肝切除术(LLR)国际共识会议建议,浅层LPT采用HS,深层LPT采用CUSA。目前一些中心在深层LPT中使用HS。然而,HS在LLR深层离断过程中的潜在作用仍不清楚。
本研究旨在探讨与CUSA相比,HS在LLR中的可行性、安全性和效率。
这是一项随机对照试验(RCT)的研究方案。
本RCT将于2024年1月至2025年12月在四川大学华西医院进行。在此期间接受LLR的连续患者将根据指定的纳入和排除标准进行招募。参与者将被随机分配到HS组或CUSA组。主要结局是术中失血。次要结局包括实质离断速度、手术时间、转换率、术后住院时间、住院费用、发病率和死亡率。将根据肝硬化情况进行亚组分析。将采用相应的统计方法进行统计分析。
该试验已于2024年1月19日经四川大学华西医院生物医学伦理审查委员会审查并批准。
本研究将阐明HS在LLR中进行LPT的可行性、安全性和效率。研究结果将为LLR中LPT设备的选择提供更可靠的临床证据。
该研究方案于2024年4月26日在中国临床试验注册中心(http://www.chictr.org.cn)注册,注册号为ChiCTR24xxxxxx,方案版本为V2.0。 (注:原文中ChiCTR2400083493的xxxxxx为了体现注册编号格式,实际是完整编号)